Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.02% | 145.50 | 0.0% | $2678.66m | |
| BNGO | BioNano Genomics, Inc. | -2.78% | 12.23 | 0.0% | $2605.81m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 68.16 | 1.0% | $679.44m | |
| AMGN | Amgen, Inc. | 0.00% | 257.10 | 1.3% | $584.68m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 548.20 | 2.7% | $502.24m | |
| CRSP | CRISPR Therapeutics AG | 0.99% | 183.03 | 0.6% | $482.88m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.47% | 162.08 | 2.0% | $481.25m | |
| ILMN | Illumina, Inc. | 0.00% | 421.00 | 3.5% | $442.75m | |
| NVAX | Novavax, Inc. | 0.00% | 131.46 | 92.9% | $427.52m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.00% | 241.31 | 1.9% | $385.00m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.11% | 95.04 | 13.8% | $362.83m | |
| BIIB | Biogen, Inc. | 0.01% | 275.57 | 1.7% | $334.28m | |
| BNTX | BioNTech SE | -0.24% | 110.35 | 0.0% | $314.22m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 153.93 | 19.6% | $267.92m | |
| PACB | Pacific Biosciences of California, Inc. | -1.28% | 35.49 | 7.4% | $217.12m |
Company Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.